North Carolina Business Coalition on Health

Forum Sponsors

Forum Sponsors

Please join us in thanking our sponsors for this event!

All event sponsors are either Affiliate Members or Advisory Council Members of NCBGH. 
We encourage you to visit them to learn more about their services.

Platinum Sponsor

Healthcare Bluebook’s goal is to protect consumers and companies nationwide from overpriced, low-quality healthcare. Using industry-leading objective price and quality data and claims-driven ROI reporting, Bluebook’s intuitive online healthcare shopping solution provides 7,000+ employers and members with an easy-to-use benefits solution that increases movement from low-value to high-value care, driving savings and rapid ROI, and provides greater price predictability. Combined with a proven engagement methodology, Bluebook’s innovative suite of services empowers employees to become smarter healthcare shoppers, while decreasing costs and improving healthcare outcomes.

For more information, visit and follow us on LinkedIn   Facebook  Twitter

Gold Sponsors

Apree Health

apree health brings together a best-in-class engagement platform with an advanced primary care model to provide a vastly better health and care experience, improve outcomes, and significantly lower the total cost of care for a population. Its proven solutions are built on a robust data and technology foundation that provides a rich understanding of each person, a navigation experience that engages individuals in their health and care, and an integrated care team that manages the individual's whole health. apree health was formed when leading advanced primary care provider Vera Whole Health merged with digital health innovator Castlight Health in 2022. Both companies were founded in 2008. apree health partners with top U.S. employers, leading provider groups, and some of the country's largest, most progressive health plans.
Visit us at:

Coherus Biosciences

Coherus Biosciences

Coherus is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus’ strategy is to build a leading immuno-oncology franchise funded with cash generated through net sales of its diversified portfolio of FDA-approved therapeutics.

In 2021, Coherus in-licensed toripalimab, an anti-PD-1 antibody, in the United States and Canada. The Biologics License Application for toripalimab in combination with chemotherapy as treatment for recurrent or metastatic nasopharyngeal carcinoma is currently under review by the FDA..

Coherus markets UDENYCA® (pegfilgrastim-cbqv), a biosimilar of Neulasta®, CIMERLI® (ranibizumab-eqrn), a biosimilar of Lucentis®, and YUSIMRY™ (adalimumab-aqvh), a biosimilar of Humira®..

Coherus is helping employers and their employees discover healthcare savings with biosimilars..

Visit to learn more.



GRAIL is a healthcare company whose mission is to detect cancer early when it can be cured. GRAIL is focused on saving lives and improving health by pioneering new technologies for early cancer detection. Their first product, the Galleri® multi-cancer early detection test, complements guideline-recommended screenings, and can detect a cancer signal shared by more than 50 types of cancer through a routine blood draw for adults with elevated cancer risk, such as those aged 50 or older. When a cancer signal is detected, the Galleri test can predict the cancer signal origin. For important safety information visit ​ 

Milliman – IE

Milliman is one of the largest privately held consulting and actuarial firms in the world delivering fresh, innovative and unbiased perspective on benefits design, strategy and ongoing plan management. We are staffed by top industry consulting professionals, actuaries, and subject matter experts all keenly focused on delivering client value.
Visit us on the web at:Health & Group Benefits | Retirement & Benefits | Milliman | US



Progyny is a leading fertility and family building benefits solution currently serving 390+ clients, covering 5.4M lives. Infertility impacts 1 in 8 couples and family building is expanding, with more single parents by choice and LGBTQ+ needing to use assisted reproductive technology, adoption, or surrogacy to grow their family.

Progyny works with self- and fully insured clients in the US, Canada and globally, and our services span preconception, fertility, maternity, postpartum and menopause. Our model includes clinically integrated member support with robust digital tools (virtual care, app, etc.); the largest fertility focused network of providers with ongoing management for quality; equitable and comprehensive plan coverage that includes male factor fertility coverage, adoption and surrogacy support; and integrated Rx.

All together, Progyny helps members get pregnant faster and have healthier pregnancies and babies, requiring less treatment and medication. This results in key healthcare savings for employers as well as enabling them to meet DEI goals, mental health priorities and attract/retain needs. Progyny completed its initial public offering in 2019 and trades on Nasdaq under the ticker PGNY.

Come visit us at ​ 

Table Sponsors